regn5458
Showing 1 - 5 of 5
Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)
Not yet recruiting
- Relapsed Refractory Multiple Myeloma
- REGN5458
- +3 more
- (no location specified)
Feb 6, 2023
Chronic Kidney Disease (CKD) Trial in New Haven, New York, Philadelphia (REGN5459, REGN5458)
Not yet recruiting
- Chronic Kidney Disease (CKD)
- REGN5459
- REGN5458
-
New York, New YorkNew York University Langone Health - Transplant Institute
Jul 11, 2022
Multiple Myeloma Trial (REGN5458)
Available
- Multiple Myeloma
- REGN5458
- (no location specified)
Dec 9, 2021
Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)
Recruiting
- Multiple Myeloma
- REGN5458
- +7 more
-
Athens, Greece
- +8 more
Nov 30, 2022
Multiple Myeloma Trial in Worldwide (REGN5458)
Recruiting
- Multiple Myeloma
- REGN5458
-
Miami, Florida
- +26 more
Aug 16, 2022